Valeant Pharmaceuticals was created in 1960.
Librax is manufactured by Valeant Pharmaceuticals International
ICN Pharmaceuticals and Valeant Pharmaceuticals have a historical connection through a series of corporate transactions. ICN Pharmaceuticals, originally founded in 1959 by Milan Panić, was a multinational pharmaceutical company based in California, USA. It was involved in the development, manufacturing, and marketing of a range of pharmaceutical products. Valeant Pharmaceuticals, formerly known as ICN Pharmaceuticals, changed its name in 2003. The rebranding was part of a strategic decision to distance itself from past legal and financial issues and to focus on a new direction for the company. The name change from ICN Pharmaceuticals to Valeant Pharmaceuticals marked a significant transformation in the company's identity and strategic direction. Valeant pursued an aggressive acquisition strategy, acquiring numerous pharmaceutical companies and building a diverse portfolio of products across various therapeutic areas. However, it's important to note that while Valeant Pharmaceuticals evolved from ICN Pharmaceuticals, they are distinct entities with separate corporate structures, leadership, and operations. The connection between the two companies lies in their corporate history and the transformation that took place when ICN Pharmaceuticals rebranded as Valeant Pharmaceuticals.
Hikma Pharmaceuticals was created in 1978.
Lexicon Pharmaceuticals was created in 1995.
Amylin Pharmaceuticals was created in 1987.
Aché - pharmaceuticals - was created in 1922.
ARIAD Pharmaceuticals was created in 1991.
Incepta Pharmaceuticals was created in 1999.
Square Pharmaceuticals was created in 1958.
Vertex Pharmaceuticals was created in 1989.
Onyx Pharmaceuticals was created in 1992.
Acadia Pharmaceuticals was created in 1993.